European Consortium Awarded Millions to Develop Therapies for IBD, 2 Other Inflammatory Diseases

European Consortium Awarded Millions to Develop Therapies for IBD, 2 Other Inflammatory Diseases
A new European project coordinated by Kiel University in Germany has been awarded with €14.4 million euros (about $15.3 million U.S. dollars) to develop a personalized medicine approach for predicting and treating three chronic inflammatory diseases: Inflammatory bowel disease (IBD), systemic lupus erythematodes (SLE) and rheumatoid arthritis (RA). The project, “A systems medicine approach to chronic inflammatory disease” (SYSCID), was announced by the European Commission in a recent press release. The project will join academic and industry partners from nine European countries that will actively work toward discovering new ways to predict and treat
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *